Galactosamine limit analysis in total hexosamines in injectable porcine sodium heparin samples

Detalhes bibliográficos
Autor(a) principal: Santana, Andreza da Costa de
Data de Publicação: 2018
Outros Autores: Marinho, Anna Carolina Machado, Lima, Patrícia Condé de, Leitão, Ozéias de Lima, Fonseca, Debora Alves, Teixeira, Raíssa Lamin, da Conceição, Claudia Maria, Jacob, Silvana do Couto
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Vigilância Sanitária em Debate
Texto Completo: https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1033
Resumo: Introduction: Research, one of the core areas of health surveillance, has its importance justified by its search for answers to various health problems. Heparin, a biological product with anticoagulant and antithrombotic properties, has been related to adverse events between the years 2007–2008. Because of that, the official compendiums updated the monograph for raw material. However, there is a lack of monographs that evaluate the final product. Objective: The goal of this study is to propose a physicochemical method of analysis of the limits of galactosamine in total hexosamine from the finished product of porcine sodium heparin. Method: We developed an analytical method from the ionexchange high performance liquid chromatography with amperometric detection, with the appropriate evaluations of the system suitability for posterior analysis of three samples of porcine sodium heparin previously submitted to the sample preparation protocol through the Micro Bio-Spin column. Results: The samples were compared to the solution of the system suitability and raw material of porcine sodium heparin. We could detect the presence of galactosamine in one of the three analyzed samples in lower amounts than the limit stipulated by the American pharmacopeia. Conclusions: We concluded that the aforementioned method is efficient for the analysis of the finished product and that is the reason why it will be suggested to the Brazilian pharmacopeia.
id FIOCRUZ-9_73511559bf6d370ff2a75faebb34b0fb
oai_identifier_str oai:ojs.visaemdebate.incqs.fiocruz.br:article/1033
network_acronym_str FIOCRUZ-9
network_name_str Vigilância Sanitária em Debate
repository_id_str
spelling Galactosamine limit analysis in total hexosamines in injectable porcine sodium heparin samplesAnálise de limite de galactosamina em hexosaminas totais em amostras injetáveis de heparina sódica suínaHeparinQuality ControlHigh Pressure Liquid ChromatographyHealth SurveillanceHeparinaControle de QualidadeCromatografia Líquida de Alta PressãoVigilância SanitáriaIntroduction: Research, one of the core areas of health surveillance, has its importance justified by its search for answers to various health problems. Heparin, a biological product with anticoagulant and antithrombotic properties, has been related to adverse events between the years 2007–2008. Because of that, the official compendiums updated the monograph for raw material. However, there is a lack of monographs that evaluate the final product. Objective: The goal of this study is to propose a physicochemical method of analysis of the limits of galactosamine in total hexosamine from the finished product of porcine sodium heparin. Method: We developed an analytical method from the ionexchange high performance liquid chromatography with amperometric detection, with the appropriate evaluations of the system suitability for posterior analysis of three samples of porcine sodium heparin previously submitted to the sample preparation protocol through the Micro Bio-Spin column. Results: The samples were compared to the solution of the system suitability and raw material of porcine sodium heparin. We could detect the presence of galactosamine in one of the three analyzed samples in lower amounts than the limit stipulated by the American pharmacopeia. Conclusions: We concluded that the aforementioned method is efficient for the analysis of the finished product and that is the reason why it will be suggested to the Brazilian pharmacopeia.Introdução: A pesquisa, uma das vertentes da vigilância sanitária, tem sua importância justificada pela busca de respostas aos diversos prejuízos relativos à saúde. A heparina, produto biológico com propriedades anticoagulantes e antitrombóticas, esteve relacionada com eventos adversos entre 2007 e 2008. Diante do ocorrido, os compêndios oficiais atualizaram a monografia para matéria-prima. No entanto, há uma deficiência de monografias para avaliação do produto final. Objetivo: Propor método físico-químico de análise de limite de galactosamina em hexosaminas totais a partir do produto acabado de heparina sódica suína. Método: Foi desenvolvido método analítico a partir da cromatografia líquida de alta eficiência por troca iônica e detecção amperométrica, com as devidas avaliações de adequação do sistema para posterior análise de três amostras de heparina sódica suína, as quais foram previamente submetidas ao protocolo de preparo de amostra através da coluna Micro Bio-Spin™. Resultados: As amostras foram comparadas com a solução de adequação do sistema e matéria-prima de heparina sódica suína, sendo possível detectar presença de galactosamina em uma das três amostras analisadas em quantidade inferior ao limite estipulado pela Farmacopeia Americana. Conclusões: Conclui-se que o método é eficiente para análise do produto acabado e, por isso, será sugerido à Farmacopeia Brasileira.Instituto Nacional de Controle de Qualidade em Saúde2018-05-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfapplication/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/103310.22239/2317-269X.01033Health Surveillance under Debate: Society, Science & Technology ; Vol. 6 No. 2 (2018): May; 61-66Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 6 Núm. 2 (2018): Puede; 61-66Vigil Sanit Debate, Rio de Janeiro; v. 6 n. 2 (2018): Maio; 61-662317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporenghttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1033/447https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1033/485Copyright (c) 2018 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debatehttps://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessSantana, Andreza da Costa deMarinho, Anna Carolina MachadoLima, Patrícia Condé deLeitão, Ozéias de LimaFonseca, Debora AlvesTeixeira, Raíssa Laminda Conceição, Claudia MariaJacob, Silvana do Couto2023-06-27T15:10:49Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/1033Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-06-27T15:10:49Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.none.fl_str_mv Galactosamine limit analysis in total hexosamines in injectable porcine sodium heparin samples
Análise de limite de galactosamina em hexosaminas totais em amostras injetáveis de heparina sódica suína
title Galactosamine limit analysis in total hexosamines in injectable porcine sodium heparin samples
spellingShingle Galactosamine limit analysis in total hexosamines in injectable porcine sodium heparin samples
Santana, Andreza da Costa de
Heparin
Quality Control
High Pressure Liquid Chromatography
Health Surveillance
Heparina
Controle de Qualidade
Cromatografia Líquida de Alta Pressão
Vigilância Sanitária
title_short Galactosamine limit analysis in total hexosamines in injectable porcine sodium heparin samples
title_full Galactosamine limit analysis in total hexosamines in injectable porcine sodium heparin samples
title_fullStr Galactosamine limit analysis in total hexosamines in injectable porcine sodium heparin samples
title_full_unstemmed Galactosamine limit analysis in total hexosamines in injectable porcine sodium heparin samples
title_sort Galactosamine limit analysis in total hexosamines in injectable porcine sodium heparin samples
author Santana, Andreza da Costa de
author_facet Santana, Andreza da Costa de
Marinho, Anna Carolina Machado
Lima, Patrícia Condé de
Leitão, Ozéias de Lima
Fonseca, Debora Alves
Teixeira, Raíssa Lamin
da Conceição, Claudia Maria
Jacob, Silvana do Couto
author_role author
author2 Marinho, Anna Carolina Machado
Lima, Patrícia Condé de
Leitão, Ozéias de Lima
Fonseca, Debora Alves
Teixeira, Raíssa Lamin
da Conceição, Claudia Maria
Jacob, Silvana do Couto
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Santana, Andreza da Costa de
Marinho, Anna Carolina Machado
Lima, Patrícia Condé de
Leitão, Ozéias de Lima
Fonseca, Debora Alves
Teixeira, Raíssa Lamin
da Conceição, Claudia Maria
Jacob, Silvana do Couto
dc.subject.por.fl_str_mv Heparin
Quality Control
High Pressure Liquid Chromatography
Health Surveillance
Heparina
Controle de Qualidade
Cromatografia Líquida de Alta Pressão
Vigilância Sanitária
topic Heparin
Quality Control
High Pressure Liquid Chromatography
Health Surveillance
Heparina
Controle de Qualidade
Cromatografia Líquida de Alta Pressão
Vigilância Sanitária
description Introduction: Research, one of the core areas of health surveillance, has its importance justified by its search for answers to various health problems. Heparin, a biological product with anticoagulant and antithrombotic properties, has been related to adverse events between the years 2007–2008. Because of that, the official compendiums updated the monograph for raw material. However, there is a lack of monographs that evaluate the final product. Objective: The goal of this study is to propose a physicochemical method of analysis of the limits of galactosamine in total hexosamine from the finished product of porcine sodium heparin. Method: We developed an analytical method from the ionexchange high performance liquid chromatography with amperometric detection, with the appropriate evaluations of the system suitability for posterior analysis of three samples of porcine sodium heparin previously submitted to the sample preparation protocol through the Micro Bio-Spin column. Results: The samples were compared to the solution of the system suitability and raw material of porcine sodium heparin. We could detect the presence of galactosamine in one of the three analyzed samples in lower amounts than the limit stipulated by the American pharmacopeia. Conclusions: We concluded that the aforementioned method is efficient for the analysis of the finished product and that is the reason why it will be suggested to the Brazilian pharmacopeia.
publishDate 2018
dc.date.none.fl_str_mv 2018-05-30
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
"Peer-reviewed article"
"Artículo revisado por pares"
"Artigo avaliado pelos pares"
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1033
10.22239/2317-269X.01033
url https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1033
identifier_str_mv 10.22239/2317-269X.01033
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1033/447
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1033/485
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
dc.source.none.fl_str_mv Health Surveillance under Debate: Society, Science & Technology ; Vol. 6 No. 2 (2018): May; 61-66
Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 6 Núm. 2 (2018): Puede; 61-66
Vigil Sanit Debate, Rio de Janeiro; v. 6 n. 2 (2018): Maio; 61-66
2317-269X
reponame:Vigilância Sanitária em Debate
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Vigilância Sanitária em Debate
collection Vigilância Sanitária em Debate
repository.name.fl_str_mv Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br
_version_ 1797042045176512512